Clinical evaluation of Phenserine tartrate Extended Controlled Release Tablet (ECRT) formulation in early mild Alzheimer’s disease and mild to moderate traumatic brain injury
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 75N95022R00041
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Place of performance
- Maryland, United States
Notice details come from SAM.gov. Updated .
Notice text
2 versions
Update #2 · Latest ·
Refer to the attachment for the RFP 75N95022R00041 - Amendment 01 (enclosed)
and
Attachment 23 - Additional Business Proposal Instructions-Updated (enclosed)
Update #1 ·
RFP 75N95022R00041 - Clinical evaluation of Phenserine tartrate Extended Controlled Release Tablet (ECRT) formulation in early mild Alzheimer’s disease and mild to moderate traumatic brain injury
Solicitation and attachments are enclosed.
Files
Notice history
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity